InvestorsHub Logo
Followers 5
Posts 654
Boards Moderated 1
Alias Born 10/11/2014

Re: None

Wednesday, 08/30/2017 7:23:37 AM

Wednesday, August 30, 2017 7:23:37 AM

Post# of 392
$PRVCF HUGE NEWS !!

PREVECEUTICAL MEDICAL AND SPORTS 1 MARKETING ANNOUNCE JOINT VENTURE TO DEVELOP A THERAPY FOR CONCUSSIONS

https://sports1marketing.com/


Preveceutical, Sports 1 to develop concussion therapy

2017-08-30 06:34 ET - News Release


Mr. Stephen Van Deventer reports

PREVECEUTICAL MEDICAL AND SPORTS 1 MARKETING ANNOUNCE JOINT VENTURE TO DEVELOP A THERAPY FOR CONCUSSIONS

Preveceutical Medical Inc. and Sports 1 Marketing (S1M) have entered a joint venture to develop a therapy geared toward athletes who suffer from concussions (mild traumatic brain injury) (TBI).

Through PreveCeutical's current Research and Development program connected to the Caribbean Blue Scorpion venom, PreveCeutical and S1M believe that there is therapeutic potential in the peptides and proteins to potentially treat TBI.

According to the Centers for Disease Control and Prevention website, a severe TBI not only impacts the life of an individual and their family, but it also has a large societal and economic toll. The estimated economic cost of TBI in 2010, including direct and indirect medical costs, is estimated to be approximately $76.5 billion. Additionally, the cost of fatal TBIs and TBIs requiring hospitalization, many of which are severe, account for approximately 90% of the total TBI medical costs.

PreveCeutical's Chairman and CEO, Mr. Stephen Van Deventer commented, "We are encouraged from the fact that the Caribbean Blue Scorpion venom peptides bypasses the blood brain barrier and attaches to the abnormal cells, this is an indicator that we are going in the right direction. We are delighted to have this opportunity of working with S1M on this exciting program where we hope to be able to help millions of people. David Meltzer and Warren Moon are icons in the professional sports industry. Their vision to help a lot of people are identical to ours."

S1M's Co-Founder and CEO, David Meltzer commented, "With PreveCeutical's outstanding research and leadership team, we are excited to be partnered up with such an innovative and industry leading group of people."

Completion of the joint venture will be subject to a number of conditions including the approval of the Canadian Securities Exchange.

About PreveCeutical Medical Inc.

PreveCeutical Medical Inc. is a health sciences company that develops innovative options for preventive therapies utilizing organic and nature identical products.

The Company currently has one product available for sale, the CELLB9trademark Immune System Booster. CELLB9trademark is an oral solution containing polarized and potentiated essential minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion venom. The active potentiated ingredients in the Blue Scorpion venom appear to support health at a deep cellular level, having been used for many years and in over 40 countries. The solution is colourless and odourless and can be administered orally.